The CAG repeat polymorphism of androgen receptor gene and prostate cancer: A meta-analysis

Molecular Biology Reports

Volumn 39, Issue 3, 2012, Pages 2615-2624

  Gu, Mingliang ^a   Dong, Xiaoqun ^b   Zhang, Xuezhi ^c   Niu, Wenquan ^d  

^a Chinese Academy of Sciences   (China)

^b UNIVERSITY OF TEXAS   (United States)

^c China Petrochemical Corporation   (China)

^d SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Androgen receptor gene; CAG repeat polymorphism; Meta analysis; Prostate cancer; Risk

Indexed keywords

ANDROGEN RECEPTOR;

ADULT; AGE DISTRIBUTION; AR GENE; ARTICLE; CAG REPEAT; CANCER PATIENT; CANCER RISK; CONTROLLED STUDY; GENE ACTIVITY; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; GEOGRAPHIC DISTRIBUTION; HUMAN; MAJOR CLINICAL STUDY; MALE; ONCOGENE; POPULATION GENETICS; PROSTATE CANCER; PUBLISHING; RISK ASSESSMENT; RISK REDUCTION; SYSTEMATIC REVIEW;

AGE FACTORS; DEMOGRAPHY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MODELS, STATISTICAL; POLYMORPHISM, GENETIC; PROSTATIC NEOPLASMS; PUBLICATION BIAS; RECEPTORS, ANDROGEN; REGRESSION ANALYSIS; RESEARCH DESIGN; TRINUCLEOTIDE REPEATS;

EID: 84863831491     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-011-1014-9     Document Type: Article

References (44)

1. Lippman SM, Klein EA, Goodman PJ, Lucia MS, Thompson IM, Ford LG et al (2009) Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 301:39-51
2. http://en.wikipedia.org/wiki/Prostate-cancer
3. Brown CJ, Goss SJ, Lubahn DB, Joseph DR, Wilson EM, French FS et al (1989) Androgen receptor locus on the human X chromosome: regional localization to Xq11-12 and description of a DNA polymorphism. Am J Hum Genet 44:264-269
4. Adachi H, Kume A, Li M, Nakagomi Y, Niwa H, Do J et al (2001) Transgenic mice with an expanded CAG repeat controlled by the human AR promoter show polyglutamine nuclear inclusions and neuronal dysfunction without neuronal cell death. Hum Mol Genet 10:1039-1048
5. Batch JA, Evans BA, Hughes IA, Patterson MN (1993) Mutations of the androgen receptor gene identified in perineal hypospadias. J Med Genet 30:198-201
6. Nantermet PV, Xu J, Yu Y, Hodor P, Holder D, Adamski S et al (2004) Identification of genetic pathways activated by the androgen receptor during the induction of proliferation in the ventral prostate gland. J Biol Chem 279:1310-1322
7. Nicolaiew N, Cancel-Tassin G, Azzouzi AR, Grand BL, Mangin P, Cormier L et al (2009) Association between estrogen and androgen receptor genes and prostate cancer risk. Eur J Endocrinol 160:101-106
8. Lindström S, Ma J, Altshuler D, Giovannucci E, Riboli E, Albanes D et al (2010). A large study of androgen receptor germline variants and their relation to sex hormone levels and prostate cancer risk. Results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium. J Clin Endocrinol Metab, Jun 9 [Epub ahead of print]
9. Gambaro G, Anglani F, D'Angelo A (2000) Association studies of genetic polymorphisms and complex disease. Lancet 355:308-311
10. Chang BL, Zheng SL, Hawkins GA, Isaacs SD, Wiley KE, Turner A et al (2002) Polymorphic GGC repeats in the androgen receptor gene are associated with hereditary and sporadic prostate cancer risk. Hum Genet 110:122-129
11. Cohn LD, Becker BJ (2003) How meta-analysis increases statistical power. Psychol Methods 8:243-253
12. Borenstein M, Hedges LV, Higgins JPT, Rothstein HR (2009) Introduction to meta-analysis. Wiley, Chichester
13. Stanford JL, Just JJ, Gibbs M, Wicklund KG, Neal CL, Blumenstein BA et al (1997) Polymorphic repeats in the androgen receptor gene: molecular markers of prostate cancer risk. Cancer Res 57:1194-1198
14. Giovannucci E, Stampfer MJ, Krithivas K, Brown M, Dahl D, Brufsky A et al (1997) The CAG repeat within the androgen receptor gene and its relationship to prostate cancer. Proc Natl Acad Sci USA 94:3320-3323
15. Ingles SA, Ross RK, Yu MC, Irvine RA, La Pera G, Haile RW et al (1997) Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor. J Natl Cancer Inst 89:166-170
16. Correa-Cerro L, Wöhr G, Häussler J, Berthon P, Drelon E, Mangin P et al (1999) (CAG)nCAA and GGN repeats in the human androgen receptor gene are not associated with prostate cancer in a French-German population. Eur J Hum Genet 7:357-362
17. Hsing AW, Gao YT, Wu G, Wang X, Deng J, Chen YL et al (2000) Polymorphic CAG and GGN repeat lengths in the androgen receptor gene and prostate cancer risk: a populationbased case-control study in China. Cancer Res 60:5111-5116
18. Xue W, Irvine RA, Yu MC, Ross RK, Coetzee GA, Ingles SA (2000) Susceptibility to prostate cancer: interaction between genotypes at the androgen receptor and prostate-specific antigen loci. Cancer Res 60:839-841
19. Chen C, Lamharzi N, Weiss NS, Etzioni R, Dightman DA, Barnett M et al (2002) Androgen receptor polymorphisms and the incidence of prostate cancer. Cancer Epidemiol Biomarkers Prev 11:1033-1040
20. Huang SP, Chou YH, Chang WS, Wu MT, Yu CC, Wu T et al (2003) Androgen receptor gene polymorphism and prostate cancer in Taiwan. J Formos Med Assoc 102:680-686
21. Li C, Grönberg H, Matsuyama H, Weber G, Nordenskjöld M, Naito K, Bergh A et al (2003) Difference between Swedish and Japanese men in the association between AR CAG repeats and prostate cancer suggesting a susceptibility-modifying locus overlapping the androgen receptor gene. Int J Mol Med 11:529-533
22. Gilligan T, Manola J, Sartor O, Weinrich SP, Moul JW, Kantoff PW (2004) Absence of a correlation of androgen receptor gene CAG repeat length and prostate cancer risk in an African- American population. Clin Prostate Cancer 3:98-103
23. Platz EA, Leitzmann MF, Rifai N, Kantoff PW, Chen YC, Stampfer MJ et al (2005) Sex steroid hormones and the androgen receptor gene CAG repeat and subsequent risk of prostate cancer in the prostate-specific antigen era. Cancer Epidemiol Biomarkers Prev 14:1262-1269
24. Krishnaswamy V, Kumarasamy T, Venkatesan V, Shroff S, Jayanth VR, Paul SF (2006) South Indian men with reduced CAG repeat length in the androgen receptor gene have an increased risk of prostate cancer. J Hum Genet 51:254-257
25. Andersson P, Varenhorst E, Söderkvist P (2006) Androgen receptor and vitamin D receptor gene polymorphisms and prostate cancer risk. Eur J Cancer 42:2833-2837
26. Sieh W, Edwards KL, Fitzpatrick AL, Srinouanprachanh SL, Farin FM, Monks SA et al (2006) Genetic susceptibility to prostate cancer: prostate-specific antigen and its interaction with the androgen receptor (United States). Cancer Causes Control 17:187-197
27. Edwards SM, Badzioch MD, Minter R, Hamoudi R, Collins N, Ardern-Jones A et al (1999) Androgen receptor polymorphisms: association with prostate cancer risk, relapse and overall survival. Int J Cancer 84:458-465
28. Santos ML, Sarkis AS, Nishimoto IN, Nagai MA (2003) Androgen receptor CAG repeat polymorphism in prostate cancer from a Brazilian population. Cancer Detect Prev 27:321-326
29. Visvanathan K, Helzlsouer KJ, Boorman DW, Strickland PT, Hoffman SC, Comstock GW et al (2004) Association among an ornithine decarboxylase polymorphism, androgen receptor gene (CAG) repeat length and prostate cancer risk. J Urol 171:652-655
30. Salinas CA, Austin MA, Ostrander EO, Stanford JL (2005) Polymorphisms in the androgen receptor and the prostate-specific antigen genes and prostate cancer risk. Prostate 65:58-65
31. Mittal RD, Mishra DK, Thangaraj K, Singh R, Mandhani A (2007) Is there an inter-relationship between prostate specific antigen, kallikrein-2 and androgen receptor gene polymorphisms with risk of prostate cancer in north Indian population? Steroids 72:335-341
32. Silva Neto B, Koff WJ, Biolchi V, Brenner C, Biolo KD, Spritzer PM et al (2008) Polymorphic CAG and GGC repeat lengths in the androgen receptor gene and prostate cancer risk: analysis of a Brazilian population. Cancer Invest 26:74-80
33. Modugno F, Weissfeld JL, Trump DL, Zmuda JM, Shea P, Cauley JA et al (2001) Allelic variants of aromatase and the androgen and estrogen receptors: toward a multigenic model of prostate cancer risk. Clin Cancer Res 7:3092-3096
34. Gsur A, Preyer M, Haidinger G, Zidek T, Madersbacher S, Schatzl G et al (2002) Polymorphic CAG repeats in the androgen receptor gene, prostate-specific antigen polymorphism and prostate cancer risk. Carcinogenesis 23:1647-1651
35. Mishra D, Thangaraj K, Mandhani A, Kumar A, Mittal R (2005) Is reduced CAG repeat length in androgen receptor gene associated with risk of prostate cancer in Indian population? Clin Genet 68:55-60
36. Okugi H, Nakazato H, Matsui H, Ohtake N, Nakata S, Suzuki K (2006) Association of the polymorphisms of genes involved in androgen metabolism and signaling pathways with familial prostate cancer risk in a Japanese population. Cancer Detect Prev 30:262-268
37. Lindström S, Zheng SL, Wiklund F, Jonsson BA, Adami HO, Bälter KA et al (2006) Systematic replication study of reported genetic associations in prostate cancer: strong support for genetic variation in the androgen pathway. Prostate 66:1729-1743
38. Das K, Cheah PY, Lim PL, Zain YB, Stephanie FC, Zhao Y et al (2008) Shorter CAG repeats in androgen receptor and non-GG genotypes in prostate-specific antigen loci are associated with decreased risk of benign prostatic hyperplasia and prostate cancer. Cancer Lett 268:340-347
39. Key TJ, Allen NE, Spencer EA, Travis RC (2002) The effect of diet on risk of cancer. Lancet 360:861-868
40. Antognelli C, Mearini L, Talesa VN, Giannantoni A, Mearini E (2005) Association of CYP17, GSTP1, and PON1 polymorphisms with the risk of prostate cancer. Prostate 63:240-251
41. Visakorpi T, Hyytinen E, Koivisto P, Tanner M, Keinänen R, Palmberg C et al (1995) In vivo amplification of the androgen receptor gene and progression of human prostate cancer. Nat Genet 9:401-406
42. Gelmann EP (2002) Molecular biology of the androgen receptor. J Clin Oncol 20:3001-3015
43. Cardon LR, Bell JI (2001) Association study designs for complex diseases. Nat Rev Genet 2:91-99
44. Hunter DJ, Riboli E, Haiman CA, Albanes D, Altshuler D, Chanock SJ et al (2005) A candidate gene approach to searching for low-penetrance breast and prostate cancer genes. Nat Rev Cancer 5:977-985